Clinical trials are facing new and evolving challenges as costs increase and approval timelines remain lengthy. Modernisation of processes and utilisation of novel technologies can help overcome such ...
Community collaboration is just as essential as a tailored clinical trial design to best investigate the effects of a disease on a specific patient population, Amir Fathi, MD, director of the leukemia ...
Panelist and director of the leukemia program at Massachusetts General Hospital, Amir Fathi, MD, explained that catchment ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease marked by irreversible fibrosis and poor prognosis. Growing disease awareness and improved diagnostics are expanding the ...
Otis Johnson, PhD, MPA, founder and principal consultant at Vantix Operations, discusses why suppliers must shift from ESG ...
GlobalData on MSN
MHRA outlines upcoming IVD submission shift for clinical trials
From 28 April, IVDs used clinical trials will be subject to an upfront assessment by the MHRA as part of a Clinical Trial of ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
1don MSN
Clinical trial explores whether a genetic test can improve early detection of prostate cancer
A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the Company that explains ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results